Valion Bio, Inc.
VBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787740
No open-market purchases or sales by Valion Bio, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $205.6K in total; no superinvestor holds it.
Holders of 5% or more of VBIO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Valion Bio, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Murchinson Ltd. | 13G | 9.99%440.2K shares | New | Jul 17, 20261 filing | Jul 17, 2026 | SEC |
| 3i, LP | 13D/A | 9.90%3.33M shares | 0.00 ppfrom 9.90% | Feb 27, 20268 filings | Aug 27, 2026 | SEC |
| 3i, LP | 13G/A | 9.90%132.7K shares | 0.00 ppfrom 9.90% | Sep 2, 20263 filings | Sep 4, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
17 Schedule 13D and 13G filings on Valion Bio, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 4, 20268:12 PM ET | 3i, LPand 3 others | 13G/A | 9.90%132.7K shares | 0.00 ppfrom 9.90% | Sep 4, 2026 | SEC |
| Sep 3, 20268:30 PM ET | 3i, LPand 3 others | 13D/A | 9.90%132.7K shares | 0.00 ppfrom 9.90% | Sep 3, 2026 | SEC |
| Sep 2, 20268:51 PM ET | 3i, LPand 3 others | 13D/A | 9.90%133.0K shares | – | Aug 31, 2026 | SEC |
| Aug 27, 20268:33 PM ET | 3i, LPand 3 others | 13D/A | 9.90%3.33M shares | 0.00 ppfrom 9.90% | Aug 25, 2026 | SEC |
| Aug 24, 20267:41 PM ET | 3i, LPand 3 others | 13D/A | 9.90%2.10M shares | 0.00 ppfrom 9.90% | Aug 20, 2026 | SEC |
| Aug 19, 20269:09 PM ET | 3i, LPand 3 others | 13D/A | 9.90%2.05M shares | 0.00 ppfrom 9.90% | Aug 17, 2026 | SEC |
| Aug 14, 20267:15 PM ET | 3i, LPand 3 others | 13D/A | 9.90%1.74M shares | 0.00 ppfrom 9.90% | Aug 12, 2026 | SEC |
| Aug 11, 20264:05 PM ET | 3i, LPand 3 others | 13D/A | 9.90%446.8K shares | 0.00 ppfrom 9.90% | Aug 9, 2026 | SEC |
| Aug 3, 20267:01 AM ET | 3i, LPand 3 others | 13D | 9.90%446.8K shares | 0.00 ppfrom 9.90% | Jul 28, 2026 | SEC |
| Jul 17, 202610:16 AM ET | Murchinson Ltd.and 8 others | 13G | 9.99%440.2K shares | New | Jun 8, 2026 | SEC |
| May 8, 20265:02 PM ET | 3i, LPand 3 others | 13G/A | 9.90%307.5K shares | 0.00 ppfrom 9.90% | Mar 31, 2026 | SEC |
| Feb 27, 20264:05 PM ET | 3i, LPand 3 others | 13G | 9.90%276.2K shares | New | Feb 21, 2026 | SEC |
| Jul 24, 2023 | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/AOld format | – | – | – | SEC |
| Jul 17, 2023 | L1 Capital Global Opportunities Master Fund, Ltd. | 13GOld format | – | New | – | SEC |
| Feb 21, 2023 | Bigger Capital Fund L P | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Ernst Jennifer | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Claude John | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Valion Bio, Inc. shares.
No Form 144 notices for Valion Bio, Inc. are on file.